Issues of Adipokine Regulation in Idiopathic Pulmonary Arterial Hypertension and Systemic Osteopenia

Purpose: to determine the role of adipokines and vascular remodeling in formation of osteoporosis in idiopathic pulmonary arterial hypertension (IPAH). Materials and methods. Functional and hemodynamic parameters, bone mineral density (BMD) T-score in lumbar spine (LS) and femoral neck (FN), blood serum levels of leptin, adiponectin, visfatin and endothelin-1 were measured in 27 patients with severe IPAH and 30 healthy volunteers. Results. Half of IPAH patients had osteoporosis. Serum levels of leptin, adiponectin, visfatin and endothelin-1 in IPAH group were higher than in healthy volunteers. BMD T-score was directly related to results of 6-minute walk test and inversely related to pulmonary vascular resistance (PVR). Circulating adiponectin and visfatin concentrations correlated with PVR; endothelin-1 concentration was directly related to pulmonary arterial systolic pressure, cardiac index and PVR. Relations between BMD T-score and circulating adiponectin, visfatin, and endothelin-1 were inverse. Positive correlations existed between serum adiponectin, visfatin and endothelin-1 levels. Conclusion. Results of our study confirm the important role of adipokine and endotheline dysregulation in development of hemodynamic disorders in severe IPAH and evidence for their possible involvement in formation of osteopenic syndrome.

идиопатическая легочная гипертензия, остеопороз, эндотелин-1, лептин, адипонектин, idiopathic pulmonary arterial hypertension, osteoporosis, endothlin-1, leptin, adiponectin

1. Lourenco A., Fontoura D., Henriques-Coelho T. et al. Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol 2012;155:350-361. doi: 10.1016/ j. ijcard. 2011.05.066

2. Kochetkova E. A., Ugay L. G., Maystrovskaya Yu. V. et al. New mechanisms of osteoporosis formation in case of terminal lung disease. Pacific Medical J 2013;4:72-75.

3. Uzum A. K., Aydin M. M., Tutuncu Yi. et al. Serum grelin and adipinectin are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients. Eur J Internal Medicine 2014;25:364-369. doi: 10.1016/j. ejim. 2013.02.012

4. Sumino H., Ichikawa S., Kasama S. et al. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circ J 2007;71:1555-1559.

5. Alangiakrishman K., Juby A., Hanley D. et al. Role of vascular factors in osteoporosis. J Gerontol 2003;58:362-366.

6. Galiè N., Humbert M., Vachiery J. L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International S ociety for Heart and Lung Transplantation (iSHLt). Eur Heart J 2016;37 (1):67-119.

7. Nakanishi K., Takeda Y., Tetsumoto S. et al. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice. Implications for therapy. Am J Respir Crit Care Med 2011;183:1164-1175. doi: 10.1164/rccm. 201007-1091OC

8. Tschopp O., Schmid C., Speich R. et al. Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest 2006;129:1002-1008.

9. Malik N., McCarthy K., Minai O. A. Prevalence and significance of decreased bone density in pulmonary arterial hypertension. South Med J 2012;105 (7):344-9. doi: 10.1097/SMJ. 0b013e31825b8117

10. Vondracek S. F., Voelkel N. F., McDermott M. T., Valdez C. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009;4:267-277.

11. Zheng Y., Ma A., Wang Q. et al. Relation of leptin, ghrelin and inflammatory cytokines with body mass index in pulmonary tuberculosis patients with and without type 2 diabetes mellitus. PLoS One 2013;8 (11):e80122. http://dx.doi.org/10.1371/journal. pone. 0080122

12. Pobeha P., Ukropec J., Skyba P. et al. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone 2011;48 (5):1008-1014. doi: 10.1016/j. bone. 2011.02.017

13. Summer R., Fiack C. A., Ikeda Y. et al. Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. Am J Physiol Lung Cell Mol Physiol 2009;297: L432 - L438. doi: 10.1152/ajplung. 90599.2008

14. Kistorp C., Faber J., Galatius S. et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-1762.

15. Santos M., Reis A., Gonçalves F. et al. Adiponectin levels are elevated in patients with pulmonary arterial hypertension. Clin Cardiol 2014;37 (1):21-25. doi: 10.1002/clc. 22210.

16. Huertas A., Tu L., Gambaryan N. et al. Leptin and regulatory Tlymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 2012;40:895-904.

17. Mohiti-Ardekani J., Soleymani-Salehabadi H., Owlia M. B., Mohiti A. Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J Bone Miner Metab 2014;32:400-404. doi: 10.1007/s00774-013-0511-4

18. Julia C., Czernichow S., Charnaux N. et al. Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes. Diabetes Res Clin Pract 2014;105 (2):231-238. doi: 10.1016/j. diabres. 2014.05.001

19. Benza R. L., Gomberg-Maitland M., Demarco T. et al. Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2015;192 (11):1345-1354. doi: 10.1164/rccm. 201501-0196OC

20. Delgado-Frias E., López-Mejias R., Genre F. et al. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis. Clin Exp Rheumatol 2015;33 (2):241-249.

21. Serizawa K., Yogo K., Tashiro Y. et al. Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats. J Endocrinol 2016;228 (2):75-84. doi: 10.1530/JOE-15-0332.

22. Mestek M. L., Weil B. R., Greiner J. J. et al. Osteopenia and endothelin-1-mediated vasconstrictor tone in postmenopausal women. Bone 2010;47 (3):542-545. doi: 10.1016/j. bone. 2010.05.041.

23. Funada Y., Nishimura Y., Youkoyama M. Imbalance of matrix metal-loproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice. Kobe J Med Sci 2004;50:59-67.

24. Prasad M., Reriani M., Khosla S. et al. Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women. Vasc Health Risk Manag 2014;10:533-538. doi: 10.2147/VHRM. S63580.

25. Madonna R., Novo G., Balistreri C. R. Cellular and molecular basis of the imbalance between vascular damage and repair in aging and age-related diseases: As biomarkers and targets for new treatments. Mech Ageing Dev 2016 Mar 15. pii: S0047-6374 (16) 30026-4. doi: 10.1016/j. mad. 2016.03.005.

26. Withers S. B., Bussey C. E., Saxton S. N. et al. Mechanisms of adiponectin-associated perivascular function in vascular disease. Arterioscler Thromb Vasc Biol 2014;34 (8):1637-1642. doi: 10.1161 / AT VBAHA. 114.303031.

27. Oda A., Taniguchi T., Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001;47:141-150.